Volume 10 Issue 6
Nov.  2019
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2019  >  10(6): 696-701
Chen Tuo, Li Ruidong, Ying Yue, et al. Next generation sequencing screening for human parvovirus B19 infection after liver transplantation and the analysis of related risk factors[J]. ORGAN TRANSPLANTATION, 2019, 10(6): 696-701. doi: 10.3969/j.issn.1674-7445.2019.06.011
Citation: Chen Tuo, Li Ruidong, Ying Yue, et al. Next generation sequencing screening for human parvovirus B19 infection after liver transplantation and the analysis of related risk factors[J]. ORGAN TRANSPLANTATION, 2019, 10(6): 696-701. doi: 10.3969/j.issn.1674-7445.2019.06.011
shu

Next generation sequencing screening for human parvovirus B19 infection after liver transplantation and the analysis of related risk factors

doi: 10.3969/j.issn.1674-7445.2019.06.011

  • Department of General Surgery, Liver Transplantation Center, Huashan Hospital Affiliated to Fudan University, Shanghai 200040, China

More Information
  • Corresponding author: Wang Zhengxin,Email：wangzhengxin@huashan.org.cn
  • Received Date: 2019-08-10
    Available Online: 2021-01-19
  • Publish Date: 2019-11-15
    Abstract
  •   Objective  To summarize the screening Methods for human parvovirus (HPV) B19 infection after liver transplantation and analyze the related risk factors.  Methods  Clinical data of 86 recipients were retrospectively analyzed. According to the Results of next generation sequencing (NGS), all recipients were divided into the HPV B19 infection group and control group. Clinical characteristics, treatment regime and clinical prognosis of patients infected with HPV B19 were analyzed. The risk factors of HPV B19 infection were analyzed using univariate and multivariate Logistic regression model by forward LR step method.  Results  Nine of the 86 recipients developed fever and progressive anemia with unexplained reasons at approximately 2 weeks after liver transplantation. NGS detection demonstrated that HPV B19 was positive and they were diagnosed with pure red cell aplasia (PRCA) caused by HPV B19 infection. After intravenous immunoglobulins (IVIG) was given and the immunosuppressant therapy was adjusted, the hemoglobin levels in all patients were significantly increased. The Results of multivariate analysis revealed that low serum globulin level in peripheral blood at postoperative 7 d [odds ratio (OR) =0.749, P=0.040] and young age (OR=0.937, P=0.038) were the independent risk factors of HPV B19 infection after liver transplantation.  Conclusions   HPV B19 infection should be considered in relatively young patients with unexplained hemoglobin decline early after liver transplantation. NGS screening is an effective method for early diagnosis of HPV B19 infection. Low serum globulin level in peripheral blood at postoperative 7 d and young age may be independent risk factors of the incidence of HPV B19 infection.

     

    • FullText(HTML)
  • loading
    • References(26)
  • [1]
    TSCHÖPE C, ELSANHOURY A, SCHLIEKER S, et al. Immunosuppression in inflammatory cardiomyopathy and parvovirus B19 persistence[J]. Eur J Heart Fail, 2019, DOI: 10.1002/ejhf.1560[Epubahead of print].
    [2]
    SHIN H, PARK S, LEE GW, et al. Parvovirus B19 infection presenting with neutropenia and thrombocytopenia: three case reports[J]. Medicine (Baltimore), 2019, 98(35):e16993. DOI: 10.1097/MD.0000000000016993.
    [3]
    EID AJ, ARDURA MI, AST Infectious Diseases Community of Practice. Human parvovirus B19 in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice[J]. Clin Transplant, 2019, 33(9):e13535. DOI: 10.1111/ctr.13535.
    [4]
    DEURENBERG RH, BATHOORN E, CHLEBOWICZ MA, et al. Application of next generation sequencing in clinical microbiology and infection prevention[J]. J Biotechnol, 2017, 243:16-24. DOI: 10.1016/j.jbiotec. 2016.12.022.
    [5]
    PARKER J, CHEN J. Application of next generation sequencing for the detection of human viral pathogens in clinical specimens[J]. J Clin Virol, 2017, 86:20-26. DOI: 10.1016/j.jcv.2016.11.010.
    [6]
    李瑞东, 王正昕.肝移植术后免疫抑制剂的个体化用药[J/CD].中华临床医师杂志(电子版), 2013, 7(1):5-6. DOI: 10.3877/cma.j.issn.1674-0785.2013.01.003.

    LI RD, WANG ZX. Individualized use of immunosuppressants after liver transplantation[J/CD]. Chin J Clin (Electr Edit), 2013, 7(1):5-6. DOI: 10.3877/cma.j.issn.1674-0785.2013.01.003.
    [7]
    ORAMAS DM, SETTY S, YELDANDI V, et al. A case report ofparvovirus B19infection in a renal allograft[J]. Int J Surg Pathol, 2017, 25(7):648-651. DOI: 10.1177/1066896917712452.
    [8]
    ZHANG M, ZHONG X, ZHANG W, et al. Human parvovirus B19 infection induced pure red cell aplasia in liver transplant recipients[J]. Int J Clin Pract Suppl, 2015(183):29-34. DOI: 10.1111/ijcp.12664.
    [9]
    任庆旗, 鞠卫强, 王东平, 等.肝移植后人细小病毒B19感染导致单纯红细胞再生障碍性贫血一例[J].中华器官移植杂志, 2016, 37(3):144-149. DOI: 10.3760/cma.j.issn.0254-1785.2016.03.004.

    REN QQ, JU WQ, WANG DP, et al. Diagnosis and treatment of pure red cell aplasia caused by human parvovirus B19 after liver transplantation: report of one case and literature review[J]. Chin J Organ Transplant, 2016, 37(3):144-149. DOI:10.3760/cma.j.issn. 0254-1785.2016.03.004.
    [10]
    张达利, 臧红, 高银杰, 等.肝移植术后发生人细小病毒B19相关纯红细胞再生障碍性贫血的临床特点分析[J].临床肝胆病杂志, 2017, 33(1):146-149. DOI:10.3969 /j.issn.1001-5256.2017.01.032.

    ZHANG DL, ZANG H, GAO YJ, et al. Clinical features of pure red cell aplasia associated with human parvovirus B19 infection after liver transplantation[J]. J Clin Hepatol, 2017, 33(1):146-149. DOI: 10.3969/j.issn.1001-5256.2017.01.032.
    [11]
    蒋密, 罗楚彬, 战昊, 等.肝移植患者人类微小病毒B19感染与相关贫血的临床特点分析[J].中国临床医学, 2018, 25(3):405-408. DOI:10.12025/j.issn.1008-6358. 2018.20180377.

    JIANG M, LUO CB, ZHAN H, et al. Clinical characteristic analysis on anemia associated with human parvovirus B19 infection in liver transplant recipients[J]. Chin J Clin Med, 2018, 25(3):405-408. DOI:10.12025/j.issn.1008-6358. 2018.20180377.
    [12]
    COSSART YE, FIELD AM, CANT B, et al. Parvovirus-like particles in human sera[J]. Lancet, 1975, 1(7898):72-73. doi: 10.1016-S0140-6736(75)91074-0/
    [13]
    SIM JY, CHANG LY, CHEN JM, et al. Human parvovirus B19 infection in patients with or without underlying diseases[J]. J Microbiol Immunol Infect, 2019, 52(4):534-541. DOI: 10.1016/j.jmii.2019.05.009.
    [14]
    KERR JR. A review of blood diseases and cytopenias associated with human parvovirus B19 infection[J]. Rev Med Virol, 2015, 25(4):224-240. DOI: 10.1002/rmv.1839.
    [15]
    SERVANT-DELMAS A, MORINET F. Update of the human parvovirus B19 biology[J]. Transfus Clin Biol, 2016, 23(1):5-12. DOI: 10.1016/j.tracli.2015.11.006.
    [16]
    PABISIAK K, STĘPNIEWSKA J, CIECHANOWSKI K. Pure red cell aplasia after kidney transplantation: parvovirus B19 culprit or coincidence?[J]. Ann Transplant, 2019, 24:123-131. DOI: 10.12659/AOT.913663.
    [17]
    CRABOL Y, TERRIER B, ROZENBERG F, et al. Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus B19 infection: a retrospective study of 10 patients and review of the literature[J]. Clin Infect Dis, 2013, 56(7):968-977. DOI: 10.1093/cid/cis1046.
    [18]
    KARRASCH M, SCHMIDT V, HAMMER A, et al. Chronic persistent parvovirus B19 bone marrow infection resulting in transfusion-dependent pure red cell aplasia in multiple myeloma after allogeneic haematopoietic stem cell transplantation and severe graft versus host disease[J]. Hematology, 2017, 22(2):93-98. DOI: 10.1080/ 10245332.2016.1183288.
    [19]
    顾向前, 张海明, 滕大洪, 等.肝移植术后早期血清球蛋白水平的变化规律及其临床意义[J/CD].实用器官移植电子杂志, 2017, 5(1):23-27. DOI:10.3969/j.issn. 2095-5332.2017.01.009.

    GU XQ, ZHANG HM, TENG DH, et al. Early dynamic changes of serum globulin and its clinical significance after liver transplantation[J/CD]. Pract J Organ Transplant (Electr Vers), 2017, 5(1):23-27. DOI: 10.3969/j.issn.2095-5332.2017.01.009.
    [20]
    刘琳.糖皮质激素作用机制的研究进展[J].肾脏病与透析肾移植杂志, 2014, 23(5):472-476. http://d.old.wanfangdata.com.cn/Periodical/szbytxsyzzz201405017

    LIU L. Advances in the mechanism of glucocorticoid action[J]. Chin J Nephrol Dial Transplant, 2014, 23(5): 472-476. http://d.old.wanfangdata.com.cn/Periodical/szbytxsyzzz201405017
    [21]
    欧山海, 谢金镇, 张雅丽, 等.中国厦门地区献血者细小病毒B19感染情况研究[J].中国实验血液学杂志, 2016, 24(5):1572-1576. DOI:10.7534/j.issn.1009-2137. 2016.05.052.

    OU SH, XIE JZ, ZHANG YL, et al. Prevalence of parvovirus B19 infection in Chinese Xiamen area blood donors[J]. J Exp Hematol, 2016, 24(5):1572-1576. DOI:10. 7534/j.issn.1009-2137.2016.05.052.
    [22]
    ZHANG J, REN B, HUI R, et al. Clinical heterogeneity of human parvovirus B19 infection following adult liver transplantation[J]. Medicine (Baltimore), 2018, 97(34):e12074. DOI: 10.1097/MD.0000000000012074.
    [23]
    GANAIE SS, ZOU W, XU P, et al. Phosphorylated STAT5 directly facilitates parvovirus B19 DNA replication in human erythroid progenitors through interaction with the MCM complex[J]. PLoS Pathog, 2017, 13(5):e1006370. DOI: 10.1371/journal.ppat.1006370.
    [24]
    MANARESI E, GALLINELLA G. Advances in the development of antiviral strategies against parvovirus B19[J]. Viruses, 2019, 11(7): E659. DOI: 10.3390/v11070659.
    [25]
    WÜRDINGER M, MODROW S, PLENTZ A. Impact of parvovirus B19 viremia in liver transplanted children on anemia: a retrospective study[J]. Viruses, 2017, 9(6): E149. DOI: 10.3390/v9060149.
    [26]
    XIAO C, WANG CX, LIU LS, et al. Clinical investigation of human parvovirus B19 infection after renal transplantation in China[J]. Transplant Proc, 2013, 45(4):1593-1599. DOI: 10.1016/j.transproceed.2013.02.040.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (214) PDF downloads(18) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return